Skip to main content

#USA, Novel #Influenza A Virus #Infections: 1 case of #H5N5 and 1 case of #H1N2v detected (CDC, Nov. 21 '25)

 


{Excerpt}

Novel Influenza A Virus Infections

Two confirmed human infections with novel influenza A viruses were reported to CDC this week

One infection with an influenza A(H5N5) virus was reported by the Washington State Department of Health and one infection with an influenza A(H1N2) variant (A(H1N2)v) virus was reported by the Vermont Department of Health.

One infection with an influenza A(H5N5) virus was reported by the Washington State Department of Public Health

-- The case occurred in an individual aged ≥18 years

-- This individual developed symptoms during the week ending October 25, 2025 (Week 43) and was hospitalized with their illness during the week ending November 8, 2025 (Week 45). 

-- Respiratory specimens collected at the healthcare facility tested positive for influenza A and were presumptive positive for influenza A(H5) at the University of Washington. 

-- The specimens were sent to the Washington State Public Health Laboratory where influenza A(H5) was confirmed using the CDC influenza A(H5) assay. 

-- Sequencing conducted at the University of Washington and at the CDC indicated this was an influenza A(H5N5) virus.

-- The investigation by public health officials identified that the patient kept backyard poultry that had exposure to wild birds

-- The patient remains hospitalized

-- This is the twelfth confirmed influenza A(H5) case in Washington overall. 

-- Prior confirmed cases in Washington were associated with commercial poultry exposure. 

-- This is the 71st confirmed human case of A(H5) in the United States since early 2024 and the first human case reported in the United States since February 2025.

One infection with an influenza A(H1N2)v virus was reported by the Vermont Department of Health in an individual aged ≥18 years

-- The individual developed symptoms and sought healthcare during the week ending October 4, 2025 (Week 40), was hospitalized but discharged on the same day, and has recovered from their illness. 

-- The investigation conducted by state public health officials was unable to determine whether the individual had exposure to swine or other animals, or whether the patient's close contacts exhibited any illness. 

-- No human-to-human transmission has been identified associated with this case.

-- When an influenza virus that normally circulates in swine (but not people) is detected in a person, it is called a “variant” influenza virus. Most human infections with variant influenza viruses occur following exposure to swine, but human-to-human transmission can occur. It is important to note that in most cases, variant influenza viruses have not shown the ability to spread easily and sustainably from person to person.

(...)

Source: 


Link: https://www.cdc.gov/fluview/surveillance/2025-week-46.html

____

Comments

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...